The Macrophage Galactose-Type Lectin Can Function as an Attachment and Entry Receptor for Influenza Virus

  1. Patrick C. Readinga,d
  1. aDepartment of Microbiology and Immunology, University of Melbourne, Victoria, Australia
  2. bInstitute for Medical Innovation, St. Luke's International Medical Center, Tokyo, Japan
  3. cLaboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan
  4. dWHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia

ABSTRACT

Specific protein receptors that mediate internalization and entry of influenza A virus (IAV) have not been identified for any cell type. Sialic acid (SIA), the primary attachment factor for IAV hemagglutinin, is expressed by numerous cell surface glycoproteins and glycolipids, confounding efforts to identify specific receptors involved in virus infection. Lec1 Chinese hamster ovary (CHO) epithelial cells express cell surface SIA and bind IAV yet are largely resistant to infection. Here, we demonstrate that expression of the murine macrophage galactose-type lectin 1 (MGL1) by Lec1 cells enhanced Ca2+-dependent IAV binding and restored permissivity to infection. Lec1 cells expressing MGL1 were infected in the presence or absence of cell surface SIA, indicating that MGL1 can act as a primary receptor or as a coreceptor with SIA. Lec1 cells expressing endocytosis-deficient MGL1 mediated Ca2+-dependent IAV binding but were less sensitive to IAV infection, indicating that direct internalization via MGL1 can result in cellular infection. Together, these studies identify MGL1 as a cell surface glycoprotein that can act as an authentic receptor for both attachment and infectious entry of IAV.

FOOTNOTES

    • Received 19 July 2013.
    • Accepted 12 November 2013.
  • Address correspondence to Patrick C. Reading, preading{at}unimelb.edu.au.
  • * Present address: Stella Liong, Department of Obstetrics & Gynaecology, University of Melbourne, Parkville, VIC, Australia, and Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, VIC, Australia; Michelle D. Tate, Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia.

  • Sarah L. Londrigan and Patrick C. Reading are the senior authors of this work.

  • Published ahead of print 20 November 2013

| Table of Contents